Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paula Sakemi Fukuhara"'
Autor:
Anthony B. Nesburn, Daniel H Lee, Marilyn Chwa, Paula Sakemi Fukuhara, Nitin Udar, Shari R. Atilano, M. Cristina Kenney
Publikováno v:
Journal of Ophthalmic & Vision Research, Vol 14, Iss 1, Pp 62-70 (2019)
Journal of Ophthalmic & Vision Research
Journal of ophthalmic & vision research, vol 14, iss 1
Journal of Ophthalmic & Vision Research
Journal of ophthalmic & vision research, vol 14, iss 1
Author(s): Atilano, Shari R; Lee, Daniel H; Fukuhara, Paula S; Chwa, Marilyn; Nesburn, Anthony B; Udar, Nitin; Kenney, M Cristina | Abstract: PurposeTo compare the levels of gene expression for enzymes involved in production and elimination of reacti
Autor:
Baruch D. Kuppermann, Rodrigo Donato Costa, Shari R. Atilano, David S. Boyer, G. Astrid Limb, Jaime Toledo-Corral, Kevin Schneider, J. Lucas Norman, Mohamed A. Hamid, M. Cristina Kenney, Deepika Malik, Javier Cáceres-del-Carpio, M. Tarek Moustafa, Marilyn Chwa, Paula Sakemi Fukuhara
Publikováno v:
Exp Eye Res
In the past decade, anti-vascular endothelial growth factor (VEGF) therapy has become more popular and the standard of care for several retinal diseases including exudative age-related macular degeneration (AMD) (Brown et al., 2006; Martin et al., 20
Autor:
Paula Sakemi Fukuhara
Publikováno v:
Journal of Ophthalmology & Clinical Research. 1
Purpose: To describe retinal changes in Susac Syndrome (SS), report its evolution and the importance of follow-up in these patients. Setting: The patient was being followed in the Ophthalmology Department of Irmandade Santa Casa de Misericórdia de S
Autor:
Juliana Caldas Ribeiro, Lilian Cataldi Rodrigues, M. C. R. Costa, Paula Sakemi Fukuhara, Fabíola Attié de Castro, Gislane Lelis Vilela de Oliveira, João C. S. Bizario, Daniel Giuliano Cerri, Auro Nomizo, Daniela Dover de Araújo
Publikováno v:
Journal of Neuroimmunology. 212:93-101
Myofiber degeneration, inflammation, and fibrosis are remarkable features of Duchenne muscular dystrophy. We hypothesized that the administration of imatinib mesylate, an inhibitor of tyrosine kinase and TGF-beta pro-fibrogenic activity, could improv